Literature DB >> 12214707

Immobilized artificial membrane chromatography coupled with atmospheric pressure ionization mass spectrometry.

April C Braddy1, Tamás Janáky, Laszlo Prokai.   

Abstract

Liquid chromatographic separations on monolayers of cell membrane phospholipids covalently immobilized to silica particles at high molecular density is used for mimicking solute partitioning into biological membranes that generally correlates with membrane transport. This technique called immobilized artificial membrane chromatography usually employs ultraviolet (UV) detection where a single compound is analyzed in a chromatographic run limiting thereby its throughput for drug discovery applications. For coupling with atmospheric pressure ionization mass spectrometry, the phosphate-buffered saline mobile phase was replaced with one that used ammonium acetate as a volatile buffer. While atmospheric pressure chemical ionization accommodated a purely aqueous effluent, interfacing with electrospray ionization required effluent splitting and the addition of an organic modifier (5%, v/v, acetonitrile). Neuropeptide FF antagonists as early-phase drug candidates were used for the comparative evaluation of the methods. Whereas electrospray ionization produced essentially no fragment ions, several compounds involved in our study yielded low-abundance molecular ions with atmospheric pressure chemical ionization. The use of mass spectrometry yielded data that correlated well with those obtained by the method employing UV detection. Both atmospheric pressure ionization methods permitted the simultaneous determination of the k'(IAM), capacity factors and, therefore, an increased-throughput ranking of potential new leads emerged from the drug discovery process based on affinity to artificial membranes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12214707     DOI: 10.1016/s0021-9673(02)00700-8

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  2 in total

1.  Exploratory neuropharmacological evaluation of a conformationally constrained thyrotropin-releasing hormone analogue.

Authors:  Meritxell Teixidó; Katalin Prokai-Tatrai; Xiaoli Wang; Vien Nguyen; Laszlo Prokai
Journal:  Brain Res Bull       Date:  2007-03-15       Impact factor: 4.077

Review 2.  Prodrugs of thyrotropin-releasing hormone and related peptides as central nervous system agents.

Authors:  Katalin Prokai-Tatrai; Laszlo Prokai
Journal:  Molecules       Date:  2009-02-06       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.